Celavie Biosciences

Celavet Animal Health

Celavie Biosciences advancing its five year exploratory study in Parkinson’s Disease

Celavie Biosciences CEO Sandy Solomon sat down with Proactive’s Christine Corrado at the BIO CEO & Investor Conference in New York. The California-based company is developing regenerative stem cell therapies to treat Parkinson’s disease and other central nervous system disorders.

Watch Video Here

Contact Celavie Biosciences

Changing the Paradigm of Regenerative Medicine and Stem Cell Technology